Journal article
159 Phase II study of OSI-774 given in combination with carboplatin in patients (pts) with recurrent epithelial ovarian cancer (EOC): NCIC ctg Ind.149
Authors
Hirte H; Oza A; Hoskins P; Ellard S; Grimshaw R; Dubuc-Lissoir J; Kerr I; Fisher B; Seymour L
Journal
European Journal of Cancer Supplements, Vol. 1, No. 5,
Publisher
Elsevier
Publication Date
9 2003
DOI
10.1016/s1359-6349(03)90192-3
ISSN
1359-6349